Calciphylaxis
By:
Sagar U. Nigwekar Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Search for other papers by Sagar U. Nigwekar in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 19: Issue 3
Published Online:
Dec 2020
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 19: Issue 3 (Dec 2020): Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
© American Society of Nephrology 2020
Page Count:
12
Article Category:
Research Article
Print Publication Date:
01 Dec 2020
Published Online:
Dec 2020
  • 1.

    Nigwekar SU, Thadhani R, Brandenburg VM: Calciphylaxis. N Engl J Med 378: 1704–1714, 2018 PubMed

  • 2.

    Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, et al.: Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 66: 133–146, 2015 10.1053/j.ajkd.2015.01.034 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Polizzotto MN, Bryan T, Ashby MA, Martin P: Symptomatic management of calciphylaxis: a case series and review of the literature. J Pain Symptom Manage 32: 186–190, 2006 10.1016/j.jpainsymman.2006.03.009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Riemer CA, El-Azhary RA, Wu KL, Strand JJ, Lehman JS: Underreported use of palliative care and patient-reported outcome measures to address reduced quality of life in patients with calciphylaxis: a systematic review. Br J Dermatol 177: 1510–1518, 2017 10.1111/bjd.15702 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Dutta P, Chaudet KM, Nazarian RM, Kroshinsky D, Nigwekar SU: Correlation between clinical and pathological features of cutaneous calciphylaxis. PLoS One 14: e0218155, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Ghosh T, Winchester DS, Davis MDP, El-Azhary R, Comfere NI: Early clinical presentations and progression of calciphylaxis. Int J Dermatol 56: 856–861, 2017 10.1111/ijd.13622 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Selye H, Gentile G, Prioreschi P: Cutaneous molt induced by calciphylaxis in the rat. Science 134: 1876–1877, 1961 PubMed

  • 8.

    O’Neill WC: Sodium thiosulfate: mythical treatment for a mysterious disease? Clin J Am Soc Nephrol 8: 1068–1069, 2013 10.2215/CJN.04990513 PubMed

  • 9.

    Kramann R, Brandenburg VM, Schurgers LJ, Ketteler M, Westphal S, Leisten I, et al.: Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy. Nephrol Dial Transplant 28: 856–868, 2013 10.1093/ndt/gfs466 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Weenig RH: Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 58: 458–471, 2008 10.1016/j.jaad.2007.12.006 PubMed

  • 11.

    Jeong HS, Dominguez AR: Calciphylaxis: Controversies in pathogenesis, diagnosis and treatment. Am J Med Sci 351: 217–227, 2016 10.1016/j.amjms.2015.11.015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, et al.: Calcific uraemic arteriolopathy (calciphylaxis): Data from a large nationwide registry. Nephrol Dial Transplant 32: 126–132, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Nigwekar SU, Zhao S, Wenger J, et al. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors JASN 27: 3421–3429, 2016 DOI: ASN.2015091065 [pii]

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR: Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56: 569–579, 2007 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, et al.: Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc 91: 1384–1394, 2016 10.1016/j.mayocp.2016.06.025 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Bajaj R, Courbebaisse M, Kroshinsky D, Thadhani RI, Nigwekar SU: Calciphylaxis in patients with normal renal function: A case series and systematic review. Mayo Clin Proc 93: 1202–1212, 2018 10.1016/j.mayocp.2018.06.001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Nigwekar SU, Wolf M, Sterns RH, Hix JK: Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol 3: 1139–1143, 2008 10.2215/CJN.00530108 [doi] PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Yu WY-H, Bhutani T, Kornik R, Pincus LB, Mauro T, Rosenblum MD, et al.: Warfarin-associated nonuremic calciphylaxis. JAMA Dermatol 153: 309–314, 2017 PubMed

  • 19.

    Nigwekar SU: An unusual case of nonhealing leg ulcer in a diabetic patient. South Med J 100: 851–852, 2007 10.1097/SMJ.0b013e3180f6100c PubMed

  • 20.

    Anderson DC, Stewart WK, Piercy DM: Calcifying panniculitis with fat and skin necrosis in a case of uraemia with autonomous hyperparathyroidism. Lancet 2: 323–325, 1968 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, et al.: Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32: 384–391, 1998 10.1053/ajkd.1998.v32.pm9740153 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Nigwekar SU, Solid CA, Ankers E, Malhotra R, Eggert W, Turchin A, et al.: Quantifying a rare disease in administrative data: The example of calciphylaxis. J Gen Intern Med 29[Suppl 3]: S724–S731, 2014 10.1007/s11606-014-2910-1 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Sowers KM, Hayden MR: Calcific uremic arteriolopathy: Pathophysiology, reactive oxygen species and therapeutic approaches. Oxid Med Cell Longev 3: 109–121, 2010 10.4161/oxim.3.2.11354 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Nigwekar SU, Bhan I, Turchin A, Skentzos SC, Hajhosseiny R, Steele D, et al.: Statin use and calcific uremic arteriolopathy: A matched case-control study. Am J Nephrol 37: 325–332, 2013 10.1159/000348806 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Nigwekar SU, Nazarian RM: Cutaneous calcification in patients with kidney disease is not always calciphylaxis. Kidney Int 94: 244–246, 2018 10.1016/j.kint.2018.04.019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Hayashi M: Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 17: 498–503, 2013 10.1007/s10157-013-0782-z PubMed

  • 27.

    Zhang Y, Corapi KM, Luongo M, Thadhani R, Nigwekar SU: Calciphylaxis in peritoneal dialysis patients: A single center cohort study. Int J Nephrol Renovasc Dis 9: 235–241, 2016 10.2147/IJNRD.S115701 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Ahmed S, O’Neill KD, Hood AF, Evan AP, Moe SM: Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37: 1267–1276, 2001 10.1053/ajkd.2001.24533 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Gaisne R, Péré M, Menoyo V, Hourmant M, Larmet-Burgeot D: Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: A case-control study. BMC Nephrol 21: 63, 2020 10.1186/s12882-020-01722-y PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Centers for Disease Control and Prevention: (https://nccd.cdc.gov/CKD).

  • 31.

    Gabel C, Chakrala T, Shah R, Danesh MJ, Dobry AS, Garza-Mayers AC, et al.: Penile calciphylaxis: A retrospective case-control study. [published online ahead of print May 15, 2020] J Am Acad Dermatol 10.1016/j.jaad.2020.05.042 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Moe SM, Chen NX: Calciphylaxis and vascular calcification: A continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18: 969–975, 2003 10.1007/s00467-003-1276-0 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Tan RYP, Juneja R, Gunawardane DN, Milton CA: Isolated mesenteric calciphylaxis with ischemic colitis in a hemodialysis patient without active cutaneous calciphylaxis: A case report of calcific uremic arteriolopathy. Kidney Med 2: 209–212, 2020 10.1016/j.xkme.2019.12.005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Nigwekar SU: Calciphylaxis. Curr Opin Nephrol Hypertens 26: 276–281, 2017 10.1097/MNH.0000000000000328 PubMed

  • 35.

    Aouizerate J, Valleyrie-Allanore L, Limal N, Ayache SS, Gherardi RK, Audard V, et al.: Ischemic myopathy revealing systemic calciphylaxis. Muscle Nerve 56: 529–533, 2017 10.1002/mus.25505 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Farooqui S, Chan A, Cullen JF, Milea D: Too young to undergo temporal artery biopsy? Calciphylaxis-related anterior ischemic optic neuropathy. Neuroophthalmology 43: 252–255, 2018 10.1080/01658107.2018.1493739 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Lin B, Srikanth P, Castle AC, Nigwekar S, Malhotra R, Galloway JL, et al.: Modulating cell fate as a therapeutic strategy. Cell Stem Cell 23: 329–341, 2018 10.1016/j.stem.2018.05.009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Chen NX, O’Neill K, Akl NK, Moe SM: Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun 449: 151–156, 2014 10.1016/j.bbrc.2014.05.005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Dominguez AR: New debates surrounding the histopathological findings of calciphylaxis: Do these give us new insights into pathogenesis of the disease? JAMA Dermatol 155: 773–775, 2019 10.1001/jamadermatol.2019.0051 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Fukagawa M, Kazama JJ: The making of a bone in blood vessels: From the soft shell to the hard bone. Kidney Int 72: 533–534, 2007 10.1038/sj.ki.5002440 PubMed

  • 41.

    Colboc H, Moguelet P, Bazin D, Carvalho P, Dillies AS, Chaby G, et al..; Groupe Angio-Dermatologie of the French Society of Dermatology: Localization, morphologic features, and chemical composition of calciphylaxis-related skin deposits in patients with calcific uremic arteriolopathy. JAMA Dermatol 155: 789–796, 2019 10.1001/jamadermatol.2019.0381 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Nigwekar SU, Bloch DB, Nazarian RM, Vermeer C, Booth SL, Xu D, et al.: Vitamin K-dependent carboxylation of matrix gla protein influences the risk of calciphylaxis. J Am Soc Nephrol 28: 1717–1722, 2017 10.1681/ASN.2016060651 [doi] PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Nigwekar SU, Thadhani R: Long-term anticoagulation for patients receiving dialysis. Circulation 138: 1530–1533, 2018 10.1161/CIRCULATIONAHA.118.037091 PubMed

  • 44.

    Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S: Vitamin K in chronic kidney disease. Nutrients 11: E168, 2019 10.3390/nu11010168 PubMed

  • 45.

    Portales-Castillo I, Kroshinsky D, Malhotra CK, Culber-Costley R, Cozzolino MG, Karparis S, et al.: Calciphylaxis as a drug induced adverse event. Expert Opin Drug Saf 18: 29–35, 2019 10.1080/14740338.2019.1559813 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Galloway PA, El-Damanawi R, Bardsley V, Pritchard NR, Fry AC, Ojha SK, et al.: Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease. Nephron 129: 197–201, 2015 10.1159/000371449 [doi] PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Nigwekar SU, Jiramongkolchai P, Wunderer F, Bloch E, Ichinose R, Nazarian RM, et al.: Increased bone morphogenetic protein signaling in the cutaneous vasculature of patients with calciphylaxis. Am J Nephrol 46: 429–438, 2017 10.1159/000484418 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP: Cutaneous calciphylaxis: A retrospective histopathologic evaluation. Am J Dermatopathol 35: 582–586, 2013 10.1097/DAD.0b013e31827c7f5d PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49.

    Au S, Crawford RI: Three-dimensional analysis of a calciphylaxis plaque: Clues to pathogenesis. J Am Acad Dermatol 47: 53–57, 2002 PubMed

  • 50.

    Hayden MR, Kolb LG, Khanna R: Calciphylaxis and the cardiometabolic syndrome. J Cardiometab Syndr 1: 76–79, 2006 PubMed

  • 51.

    Janigan DT, Hirsch DJ, Klassen GA, MacDonald AS: Calcified subcutaneous arterioles with infarcts of the subcutis and skin (“calciphylaxis”) in chronic renal failure. Am J Kid Dis 35: 588–597, 2000

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    El-Azhary RA, Patzelt MT, McBane RD, Weaver AL, Albright RC, Bridges AD, et al.: Calciphylaxis: A disease of pannicular thrombosis. Mayo Clin Proc 91: 1395–1402, 2016 10.1016/j.mayocp.2016.06.026 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D: Association between hypercoagulable conditions and calciphylaxis in patients with renal disease: A case-control study. JAMA Dermatol 154: 182–187, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Ruderman I, Toussaint ND, Hawley CM, Krishnasamy R, Pedagogos E, Lioufas N, et al.: The Australian Calciphylaxis Registry: Reporting clinical features and outcomes of patients with calciphylaxis. [published online ahead of print December 19, 2019]. Nephrol Dial Transplant 10.1093/ndt/gfz256 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55.

    Brandenburg VM, Sinha S: Calciphylaxis: Another piece of the puzzle. Am J Nephrol 46: 427–428, 2017 10.1159/000484545 PubMed

  • 56.

    Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr: Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol 8: 1162–1170, 2013 10.2215/CJN.09880912 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Fine A, Zacharias J: Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 61: 2210–2217, 2002 10.1046/j.1523-1755.2002.00375.x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Zacharias JM, Fontaine B, Fine A: Calcium use increases risk of calciphylaxis: A case-control study. Perit Dial Int 19: 248–252, 1999 PubMed

  • 59.

    Li JY, Yong TY, Choudhry M, Rao N, Milton C, Juneja R, et al.: Successful treatment of calcific uremic arteriolopathy with sodium thiosulfate in a renal transplant recipient. Ren Fail 34: 645–648, 2012 10.3109/0886022X.2012.656560 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60.

    Adapa S, Naramala S, Gayam V, Koduri NM, Daggubati SR, Patel P, et al.: Calciphylaxis in a patient on home hemodialysis. J Investig Med High Impact Case Rep 8: 2324709620922718, 2020 10.1177/2324709620922718 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Kale G, Jeloka T, Shrividya S, Mulay A, Deshmukh M, Krishnan S, et al.: Calciphylaxis in a renal transplant recipient with normal graft function: A case report and review of literature. Saudi J Kidney Dis Transpl 30: 215–220, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62.

    Floege J, Kubo Y, Floege A, Chertow GM, Parfrey PS: The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE trial. Clin J Am Soc Nephrol 10: 800–807, 2015 10.2215/CJN.10221014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y; Japanese Calciphylaxis Study Group: A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 27: 1580–1584, 2012 10.1093/ndt/gfr658 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64.

    Mawad HW, Sawaya BP, Sarin R, Malluche HH: Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 52: 160–166, 1999 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Frazão JM, Martins P: Adynamic bone disease: Clinical and therapeutic implications. Curr Opin Nephrol Hypertens 18: 303–307, 2009 10.1097/MNH.0b013e32832c4df0 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Allegretti AS, Nazarian RM, Goverman J, Nigwekar SU: Calciphylaxis: A rare but fatal delayed complication of Roux-en-Y gastric bypass surgery. Am J Kidney Dis 64: 274–277, 2014 10.1053/j.ajkd.2014.02.029 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Liebman TN, Tamez R, Daly JA: Calciphylaxis in association with alcoholic cirrhosis and hepatorenal syndrome. Skinmed 18: 46–49, 2020 PubMed

  • 68.

    Avogaro A, Rattazzi M, Fadini GP: Ectopic calcification in diabetic vascular disease. Expert Opin Ther Targets 18: 595–609, 2014 10.1517/14728222.2014.894021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69.

    Harris RJ, Cropley TG: Possible role of hypercoagulability in calciphylaxis: Review of the literature. J Am Acad Dermatol 64: 405–412, 2011 10.1016/j.jaad.2009.12.007 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70.

    Zechlinski JJ, Angel JR: Calciphylaxis in the absence of renal disease: Secondary hyperparathyroidism and systemic lupus erythematosus. J Rheumatol 36: 2370–2371, 2009 10.3899/jrheum.090252 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71.

    Barri YM, Graves GS, Knochel JP: Calciphylaxis in a patient with Crohn’s disease in the absence of end-stage renal disease. Am J Kidney Dis 29: 773–776, 1997 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Malabu UH, Roberts LJ, Sangla KS: Calciphylaxis in a morbidly obese woman with rheumatoid arthritis presenting with severe weight loss and vitamin D deficiency. Endocr Pract 17: e104–e108, 2011 10.4158/EP11099.CR PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73.

    Mandelbrot DA, Santos PW, Burt RK, Oyama Y, Block GA, Ahya SN, et al.: Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation. Nephrol Dial Transplant 23: 2679–2684, 2008 10.1093/ndt/gfn036 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Sato H, Kazama JJ, Wada Y, Kuroda T, Narita I, Gejyo F, et al.: Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis. Intern Med 46: 1685–1691, 2007 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75.

    Marhaug G, Shah V, Shroff R, Varsani H, Wedderburn LR, Pilkington CA, et al.: Age-dependent inhibition of ectopic calcification: A possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 47: 1031–1037, 2008 10.1093/rheumatology/ken136 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al.: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357–366, 2003 10.1172/JCI17202 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Rothe H, Brandenburg V, Haun M, Kollerits B, Kronenberg F, Ketteler M, et al.: Ecto-5′ -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients: Data from the German Calciphylaxis Registry. PLoS One 12: e0172407, 2017 10.1371/journal.pone.0172407 [doi] PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78.

    Farah M, Crawford RI, Levin A, Chan Yan C: Calciphylaxis in the current era: Emerging ‘ironic’ features? Nephrol Dial Transplant 26: 191–195, 2011 10.1093/ndt/gfq407 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79.

    Sreedhar A, Sheikh HA, Scagliotti CJ, Nair R: Advanced-stage calciphylaxis: Think before you punch. Cleve Clin J Med 83: 562–564, 2016 10.3949/ccjm.83a.15103 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    Chaudet KM, Dutta P, Nigwekar SU, Nazarian RM: Calciphylaxis-associated cutaneous vascular calcification in noncalciphylaxis patients. Am J Dermatopathol 42: 557–563, 2020 10.1097/DAD.0000000000001519 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81.

    Ellis CL, O’Neill WC: Questionable specificity of histologic findings in calcific uremic arteriolopathy. Kidney Int 94: 390–395, 2018 10.1016/j.kint.2018.03.016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Musso CG, Enz PA, Kowalczuk A, Cozzolino M, Brandenburg V, Nigwekar S: Differential diagnosis of calciphylaxis in chronic dialysis patients. Int Urol Nephrol 52: 595–597, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83.

    Bahrani E, Perkins IU, North JP: Diagnosing calciphylaxis: A review with emphasis on histopathology. Am J Dermatopathol 42: 471–480, 2020 10.1097/DAD.0000000000001526 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84.

    McMullen ER, Harms PW, Lowe L, Fullen DR, Chan MP: Clinicopathologic features and calcium deposition patterns in calciphylaxis: Comparison with gangrene, peripheral artery disease, chronic stasis, and thrombotic vasculopathy. Am J Surg Pathol 43: 1273–1281, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85.

    Ng AT, Peng DH: Calciphylaxis. Dermatol Ther (Heidelb) 24: 256–262, 2011 10.1111/j.1529-8019.2011.01401.x PubMed

  • 86.

    Williams EA, Moy AP, Cipriani NA, Nigwekar SU, Nazarian RM: Factors associated with false-negative pathologic diagnosis of calciphylaxis. J Cutan Pathol 46: 16–25, 2019 10.1111/cup.13364 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87.

    Bonchak JG, Park KK, Vethanayagamony T, Sheikh MM, Winterfield LS: Calciphylaxis: A case series and the role of radiology in diagnosis. Int J Dermatol 55: e275–e279, 2016 10.1111/ijd.13043 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 88.

    Paul S, Rabito CA, Vedak P, Nigwekar SU, Kroshinsky D: The role of bone scintigraphy in the diagnosis of calciphylaxis. JAMA Dermatol 153: 101–103, 2017 10.1001/jamadermatol.2015.4591 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Shmidt E, Murthy NS, Knudsen JM, Weenig RH, Jacobs MA, Starnes AM, et al.: Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis. J Am Acad Dermatol 67: 1296–1301, 2012 10.1016/j.jaad.2012.05.037 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90.

    Alniemi DT, Kanner C, Stowman AM, Knapp M, McGevna L, Seward DJ, et al.: Diagnosing calciphylaxis: A series of cases with both imaging and tissue biopsy. [published online ahead of print June 8, 2020]. J Am Acad Dermatol 10.1016/j.jaad.2020.05.111 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91.

    Lloyd WR, Agarwal S, Nigwekar SU, Esmonde-White K, Loder S, Fagan S, et al.: Raman spectroscopy for label-free identification of calciphylaxis. J Biomed Opt 20: 80501, 2015 10.1117/1.JBO.20.8.080501 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92.

    Baran DT, Letts, GStA: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2001. A 70-year-old woman with end-stage renal disease and cutaneous ulcers. N Engl J Med 345: 1119–1124, 2001 10.1056/NEJMcpc312001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93.

    Hafner J: Calciphylaxis and Martorell hypertensive ischemic leg ulcer: Same pattern - one pathophysiology. Dermatology 232: 523–533, 2016 10.1159/000448245 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 94.

    Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM: Warfarin-induced skin necrosis. J Am Acad Dermatol 61: 325–332, 2009 10.1016/j.jaad.2008.12.039 PubMed

  • 95.

    Bazari H, Jaff MR, Mannstadt M, Yan S: Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers. N Engl J Med 356: 1049–1057, 2007 10.1056/NEJMcpc069038 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96.

    Baldwin C, Farah M, Leung M, Taylor P, Werb R, Kiaii M, et al.: Multi-intervention management of calciphylaxis: A report of 7 cases. Am J Kidney Dis 58: 988–991, 2011 10.1053/j.ajkd.2011.06.022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 97.

    Russo D, Capuano A, Cozzolino M, Napolitano P, Mosella F, Russo L, et al.: Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): A case series. Clin Kidney J 9: 108–112, 2016 10.1093/ckj/sfv120 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98.

    Seethapathy H, Brandenburg VM, Sinha S, El-Azhary RA, Nigwekar SU: Review: Update on the management of calciphylaxis. QJM 112: 29–34, 2019 10.1093/qjmed/hcy234 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99.

    Seethapathy H, Nigwekar SU: Revisiting therapeutic options for calciphylaxis. Curr Opin Nephrol Hypertens 28: 448–454, 2019 10.1097/MNH.0000000000000520 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 100.

    Nigwekar SU: Multidisciplinary approach to calcific uremic arteriolopathy. Curr Opin Nephrol Hypertens 24: 531–537, 2015 10.1097/MNH.0000000000000175 PubMed

  • 101.

    Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P: Treatment of calciphylaxis in CKD: A systematic review and meta-analysis. Kidney Int Rep 4: 231–244, 2018 10.1016/j.ekir.2018.10.002 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 102.

    Santos PW, He J, Tuffaha A, Wetmore JB: Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy. Int Urol Nephrol 49: 2247–2256, 2017 10.1007/s11255-017-1721-9 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103.

    Harris DG: Management of pain in advanced disease. Br Med Bull 110: 117–128, 2014 10.1093/bmb/ldu010 PubMed

  • 104.

    Roza K, George JC, Bermudez M, Mehta Z: Uremic calciphylaxis #325. J Palliat Med 20: 424–425, 2017 10.1089/jpm.2016.0513 PubMed

  • 105.

    Chinnadurai R, Sinha S, Lowney AC, Miller M: Pain management in patients with end-stage renal disease and calciphylaxis- a survey of clinical practices among physicians. BMC Nephrol 21: 403, 2020 10.1186/s12882-020-02067-2 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    McCulloch N, Wojcik SM, Heyboer M 3rd: Patient outcomes and factors associated with healing in calciphylaxis patients undergoing adjunctive hyperbaric oxygen therapy. J Am Coll Clin Wound Spec 7: 8–12, 2016 10.1016/j.jccw.2016.08.004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107.

    Tittelbach J, Graefe T, Wollina U: Painful ulcers in calciphylaxis: Combined treatment with maggot therapy and oral pentoxyfillin. J Dermatolog Treat 12: 211–214, 2001 10.1080/09546630152696035 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 108.

    Don BR, Chin AI: A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol 59: 463–470, 2003 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 109.

    Nigwekar SU, Sprague SM: We do too many parathyroidectomies for calciphylaxis. Semin Dial 29: 312–314, 2016 10.1111/sdi.12502 PubMed

  • 110.

    Amuluru L, High W, Hiatt KM, Ranville J, Shah SV, Malik B, et al.: Metal deposition in calcific uremic arteriolopathy. J Am Acad Dermatol 61: 73–79, 2009 10.1016/j.jaad.2009.01.042 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 111.

    Garza-Mayers AC, Shah R, Sykes DB, Nigwekar SU, Kroshinsky D: The successful use of apixaban in dialysis patients with calciphylaxis who require anticoagulation: A retrospective analysis. Am J Nephrol 48: 168–171, 2018 10.1159/000491881 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 112.

    King BJ, El-Azhary RA, McEvoy MT, Shields RC, McBane RD, McCarthy JT, et al.: Direct oral anticoagulant medications in calciphylaxis. Int J Dermatol 56: 1065–1070, 2017 10.1111/ijd.13685 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113.

    Zitt E, König M, Vychytil A, Auinger M, Wallner M, Lingenhel G, et al.: Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant 28: 1232–1240, 2013 10.1093/ndt/gfs548 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 114.

    Torregrosa JV, Durán CE, Barros X, Blasco M, Arias M, Cases A, et al.: Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 32: 329–334, 2012 10.3265/Nefrologia.pre2012.Jan.11137 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 115.

    Ross EA: Evolution of treatment strategies for calciphylaxis. Am J Nephrol 34: 460–467, 2011 10.1159/000332221 PubMed

  • 116.

    Gabel CK, Nguyen ED, Dobry AS, Baker O, Garza-Mayers AC, Ko LN, et al.: Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate. [published online ahead of print July 28, 2020]. J Am Acad Dermatol 10.1016/j.jaad.2020.07.090 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117.

    Singh RP, Derendorf H, Ross EA: Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis. Clin J Am Soc Nephrol 6: 1155–1159, 2011 10.2215/CJN.09671010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 118.

    Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 1: 1161–1166, 2006 10.2215/CJN.01520506 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 119.

    el-Azhary RA, Arthur AK, Davis MD, McEvoy MT, Gibson LE, Weaver AL, et al.: Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis. JAMA Dermatol 149: 63–67, 2013 10.1001/2013.jamadermatol.5 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 120.

    Sanguankeo A, Thamcharoen N, Upala S: WITHDRAWN: Calciphylaxis in a nondialysis patient treated with sodium thiosulfate and high dose of oxygen. Clin Nephrol Case Stud 5: 38–41, 2017 10.5414/CN108959 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 121.

    Levy R: Potential treatment of calciphylaxis with vitamin K(2): Comment on the article by Jacobs-Kosmin and DeHoratius. Arthritis Rheum 57: 1575–1576, 2007 10.1002/art.23107 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 122.

    Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A: Resolution of calciphylaxis after urgent kidney transplantation in 3 patients with end-stage kidney failure. Transplant Direct 2: e113, 2016 10.1097/TXD.0000000000000627 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 123.

    Sillero-Herrera A, Gomez-Herreros R, Vergara-Lopez S: Calciphylaxis. N Engl J Med 379: 398–399, 2018 10.1056/NEJMc1807324 PubMed

  • 124.

    Zakher M, Chaudhry RI, Monrroy M, Daoui S, Daoui R, Salman L, et al.: Clinical characteristics and outcomes of patients with calciphylaxis. [published online ahead of print July 14, 2020]. Am J Med Sci 10.1016/j.amjms.2020.07.017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 125.

    Robert T, Lionet A, Bataille S, Seret G: Rheopheresis: A new therapeutic approach in severe calciphylaxis. Nephrology (Carlton) 25: 298–304, 2020 10.1111/nep.13666 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 126.

    Brandenburg VM, Sinha S, Torregrosa JV, Garg R, Miller S, Canals AZ, et al.: Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: A phase 2 open-label study of patients with calciphylaxis. J Nephrol 32: 811–821, 2019 10.1007/s40620-019-00631-0 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 127.

    Perelló J, Joubert PH, Ferrer MD, Canals AZ, Sinha S, Salcedo C: First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification. Br J Clin Pharmacol 84: 2867–2876, 2018 10.1111/bcp.13752 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 128.

    O’Neil B, Southwick AW: Three cases of penile calciphylaxis: Diagnosis, treatment strategies, and the role of sodium thiosulfate. Urology 80: 5–8, 2012 10.1016/j.urology.2012.04.012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 129.

    Olaniran KO, Percy SG, Zhao S, Blais C, Jackson V, Kamdar MM, et al.: Palliative care use and patterns of end-of-life care in hospitalized patients with calciphylaxis. J Pain Symptom Manage 57: e1–e3, 2019 10.1016/j.jpainsymman.2018.10.514 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 206 141 5
Full Text Views 217 106 0
PDF Downloads 279 136 0